MicroRNAs contribute to HIV-1 latency in resting T cells. This finding could potentially be used in the development of therapies targeted to purge the latent reservoir in an effort to clear the body of virus (pages 1241–1247).
This is a preview of subscription content, log in via an institution to check access.
Kim Caesar
References
Palella, F.J. et al. N. Engl. J. Med. 338, 853–860 (1998).
Han, Y., Wind-Rotolo, M., Yang, H.C., Siliciano, J.D. & Siliciano, R.F. Nat. Rev. Microbiol. 5, 95–106 (2007).
Siliciano, J.D. et al. Nat. Med. 9, 727–728 (2003).
Lassen, K., Han, Y., Zhou, Y., Siliciano, J. & Siliciano, R.F. Trends Mol. Med. 10, 525–531 (2004).
Peterson, S., Reid, A.P., Kim, S. & Siliciano, R.F. Advances in Pharmacology HIV-1: Molecular Biology and Pathogenesis Viral Mechanisms 2nd edn., 411–425 (Academic Press, 2007).
Huang, J.-L. et al. Nat. Med. 13, 1241–1247 (2007).
Du, T. & Zamore, P.D. Cell Res. 17, 661–663 (2007).
Cullen, B.R. Nat. Immunol. 7, 563–567 (2006).
Lecellier, C.H. et al. Science 308, 557–560 (2005).
Jopling, C.L., Yi, M., Lancaster, A.M., Lemon, S.M. & Sarnow, P. Science 309, 1577–1581 (2005).
Triboulet, R. et al. Science 315, 1579–1582 (2007).
Lewis, B.P., Burge, C.B. & Bartel, D.P. Cell 120, 15–20 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Han, Y., Siliciano, R. Keeping quiet: microRNAs in HIV-1 latency. Nat Med 13, 1138–1140 (2007). https://doi.org/10.1038/nm1007-1138
Issue Date:
DOI: https://doi.org/10.1038/nm1007-1138
- Springer Nature America, Inc.
This article is cited by
-
Opioids and HIV/HCV Infection
Journal of Neuroimmune Pharmacology (2011)
-
Suppression of HIV-1 replication by microRNA effectors
Retrovirology (2009)
-
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
Nature Reviews Microbiology (2009)